Abstract: With new cfDNA NGS assays being able to detect variants from as little as 2-10ng DNA, assay validation to ensure sufficient accuracy has never been so critical. Reference materials that closely mimic real cfDNA samples are essential to support this effort. Here we present results from a comparative study into the production of cfDNA reference standards, assessing enzymatic fragmentation compared to fragmentation by sonication, and the benefit of including a size selection step.Summary: Liquid biopsies hold great promise to revolutionise the field of clinical oncology testing. cfDNA can be extracted from a routine patient blood sample and used to determine the genetic profile of a solid tumour located elsewhere within the body. This facilitates more informative disease management for the clinician, without the need for invasive surgery for the patient.
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
Development of a valid consent policy for Radiological Imaging procedures in Irish (HSE) Hospitals
MICRONUCLEI AS BIOMARKERS OF GENETIC DAMAGE IN ORAL SQUAMOUS CELL CARCINOMA
Nancy A. Shaaban 1 BDS, Hanaa S. Raslan 2 PhD, Omneya M. Ramadan 3 PhD, Ahmed S. Habib 4 PhD, Eiman I. Zaki 5 PhD
Expression of MSH2 in Head and Neck Lymphomas (A Study Utilizing Immunohistochemistry and Real-time Polymerase Chain Reaction)
Safa Fathi Abdel-Ghani, Rehab Fawzi Kasem , Dina Soliman Khater
Chemopreventive Effect of Mentha Piperita on Dimethylbenz[a]anthracene and Formaldehyde-induced Tongue Carcinogenesis in Mice (Histological and Immunohistochemical study)
Rehab F. Kasem1, Radwa H. Hegazy2,*, Mona A. A. Arafa3, Mona M. AbdelMohsen4
automated, low-cost, miniaturized RNA-Seqand DNAseqlibrary preps
SrimeenakshiSrinivasan2, PaymanehMalihi3, Peter De Hoff2, Tiffany Herrero2, To Cuong2, Joby Jenkins1, Louise Laurent2, James Hicks3, Peter Kuhn3